The Challenge

Co-pay is one of the largest levers on brand performance, yet it is budgeted and reported as a cost. Leaders can see what was spent, not what each dollar returned.

Key Challenges

  • Cost, not investment: Spend is tracked at programme level, with no return view by brand, payer or therapy area.
  • Support not targeted: The same help goes to everyone, with no view of who needs it and who doesn’t.
  • Spend unlinked to outcomes: Reporting can’t show how spend moves share retention or revenue protected.
  • Decisions without a test: Co-pay levels are set without competitive context or “what if” modelling.

Our Solution

Competitive Co-Pay Analytics treats co-pay as an investment portfolio. It unifies claims, programme, enrolment and hub data with competitor pricing and formulary data, so every dollar of spend can be tied to a return.

1
Democratized Data Access
Developed a non-SQL method for querying data within the EDF, eliminating the need for SQL knowledge.

Priced KPIs:
Each index resolves to a dollar impact, including return per $1 of co-pay spend.

2

Head-to-head benchmarking:
Brand affordability is compared against competing products and biosimilars, by payer.

3

Targeted support:
Smart segmentation shows who needs support and who doesn’t, by brand, payer, therapy area and patient segment.

4

Scenario simulation:
Test a co-pay change before committing the spend.

5

Action by function:
Every KPI carries Program Ops, Market Access and Commercial actions.

Key Impact
Return per $1
Every KPI resolves to a dollar impact, not a score
4 optimisation dimensions
Brand, payer, therapy area and patient segment, so spend goes where it pays back
The Customer
Brand and commercial leadership, Market Access, and Value and Patient Access teams at a representative global biopharmaceutical organisation, who decide where co-pay investment goes.

The Outcomes

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique. Duis cursus, mi quis viverra ornare, eros dolor interdum nulla, ut commodo diam libero vitae erat. Aenean faucibus nibh et justo cursus id rutrum lorem imperdiet. Nunc ut sem vitae risus tristique posuere.

Support Aimed Where It Pays Back:
Investment is targeted by brand, payer, therapy area and patient segment.

4 Funnel Stages Tied to Spend:
Share retention is measured against co-pay spend, from activation and fills to persistence and revenue protected.

3 Functions, One KPI View:
Program Ops, Market Access and Commercial act from the same priced KPIs, so investment decisions don’t split across teams.

Tested Before Committed:
Scenario simulation models a change, for example a $10 co-pay shift, before money is committed.

Recent Case Studies

Case study
Transforming datamanagement in a leadingpharmaceutical company withdata lens
Case study
Transforming data Transforming Biotech Field Operations: Enhancing Efficiency and Accuracy with Doc Sonar, a Gen Al-Driven Solution
Read more
Case study
Transforming datamanagement in a leadingpharmaceutical company withdata lens
Case study
Transforming data Transforming Biotech Field Operations: Enhancing Efficiency and Accuracy with Doc Sonar, a Gen Al-Driven Solution
Read more
Case study
Transforming datamanagement in a leadingpharmaceutical company withdata lens
Case study
Transforming data Transforming Biotech Field Operations: Enhancing Efficiency and Accuracy with Doc Sonar, a Gen Al-Driven Solution
Read more
Case study
Transforming datamanagement in a leadingpharmaceutical company withdata lens
Case study
Transforming data Transforming Biotech Field Operations: Enhancing Efficiency and Accuracy with Doc Sonar, a Gen Al-Driven Solution
Read more